Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical trial register · United States · industry-sponsored

Geographic Atrophy Secondary to Age-related Macular Degeneration Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9128 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 04 Nov 2026, 03:16 UTC
9128
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2189
Lead sponsors
across recruiting studies
Top states
California 6 Texas 6 Pennsylvania 5 Nevada 4 Illinois 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Geographic Atrophy Secondary to Age-related Macular Degeneration trials in the USA

8 of 9128 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Genentech, Inc.
Phase 2
321
California, North Carolina, Pennsylvania, Texas, Virginia
2027-01-08
Recruiting
Novartis Pharmaceuticals
Phase 2
272
California, Florida, Massachusetts, New Jersey, New York, Pennsylvania, Texas
2026-03-09
Recruiting
Complement Therapeutics
Phase 1/2
75
Indiana, Nevada, Texas, Wisconsin
2025-12-30
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Arizona, California, Florida, Maryland, Nevada, Pennsylvania, Texas, Utah
2025-11-10
Recruiting
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
NCT07144137Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics
Observational
75
California, Illinois, Indiana, Nevada, North Carolina, Pennsylvania, Texas, Wisconsin
2025-07-30
Recruiting
Apellis Pharmaceuticals, Inc.
Phase 2
240
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2025-06-23
Recruiting
Kriya Therapeutics, Inc.
Phase 1/2
62
Pennsylvania
2025-05-28
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
Not applicable
100
California, Connecticut, Illinois, Nevada, Ohio, Texas
2025-05-07
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/geographic-atrophy-secondary-to-age-related-macular-degeneration

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,128 studies in total at the last sync on 04 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies listing the condition Geographic Atrophy Secondary to Age-related Macular Degeneration.

How many Geographic Atrophy Secondary to Age-related Macular Degeneration trials are recruiting in the US?

8 of the 8 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Geographic Atrophy Secondary to Age-related Macular Degeneration), 8 studies
PhaseStudiesRecruitingShare
Phase 24450%
Phase 1/22225%
Not applicable1112.5%
Observational1112.5%

Most active sponsors

Lead sponsors with the most studies (Geographic Atrophy Secondary to Age-related Macular Degeneration)
Lead sponsorStudiesRecruiting
Complement Therapeutics22
ADARx Pharmaceuticals, Inc.11
Apellis Pharmaceuticals, Inc.11
Genentech, Inc.11
i-Lumen Scientific AUS PTY LTD11
Kriya Therapeutics, Inc.11
Novartis Pharmaceuticals11

Top states

Top states (Geographic Atrophy Secondary to Age-related Macular Degeneration), by number of studies with a site there
StateStudies
California6
Texas6
Pennsylvania5
Nevada4
Florida3
Illinois3
Indiana3
Arizona2
Connecticut2
North Carolina2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.